Shanghai Medicilon Inc. (SHA:688202)
China · Delayed Price · Currency is CNY 89.34
-5.12 (-5.42%)
At close: Sep 11, 2026
Shanghai Medicilon Market Cap
Shanghai Medicilon has a market cap or net worth of 12.43 billion as of September 11, 2026. Its market cap has increased by 42.30% in one year.
Market Cap
12.43B
Enterprise Value
12.17B
Revenue
1.38B
Ranking
n/a
PE Ratio
n/a
Stock Price
89.34
ChartMarket Cap Chart
Since November 5, 2019, Shanghai Medicilon's market cap has increased from 4.40B to 12.43B, an increase of 182.28%. That is a compound annual growth rate of 16.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 12.43B | 67.48% |
| Dec 31, 2025 | 7.42B | 83.97% |
| Dec 31, 2024 | 4.03B | -56.21% |
| Dec 29, 2023 | 9.21B | -50.52% |
| Dec 30, 2022 | 18.61B | -38.26% |
| Dec 31, 2021 | 30.15B | 209.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 5, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Acrobiosystems | 13.64B |
| Anhui Anke Biotechnology (Group) | 13.57B |
| Jinyu Bio-technology | 13.12B |
| HitGen | 12.53B |
| GemPharmatech | 12.51B |
| Inner Mongolia Furui Medical Science | 11.96B |
| Sino Biological,Inc. | 11.68B |
| Chengzhi | 11.38B |